How are MIC results used to determine categories in antimicrobial susceptibility testing?

Prepare for your Antimicrobial Susceptibility Testing and Rapid Diagnostics exam. Engage with flashcards and multiple choice questions, each supplemented by hints and thorough explanations. Boost your confidence and readiness for the exam!

Multiple Choice

How are MIC results used to determine categories in antimicrobial susceptibility testing?

Explanation:
Interpreting MIC results hinges on applying breakpoints that tie a numeric MIC to a clinical category. The MIC is the smallest drug concentration that inhibits growth in vitro, but by itself it doesn’t tell you whether that level of drug will work in a patient. Breakpoints are predefined thresholds for each organism–drug combination. If the MIC is at or below the breakpoint, the organism is considered susceptible; if it falls between breakpoints, it’s intermediate (often worth considering higher dosing or a specific site issue); if it is above the resistant breakpoint, the organism is resistant. These breakpoints are carefully set using pharmacokinetics and pharmacodynamics (how the drug behaves in the body and at the infection site), achievable drug concentrations with standard dosing, and clinical outcome data. So the correct approach is to translate the MIC value into a category using those breakpoints rather than reading the MIC alone as the final interpretation. The other statements overlook this: MIC alone isn’t the final verdict, so using it directly as S/I/R isn’t accurate; and disk diffusion uses zone diameters with separate interpretive criteria, not MIC values, to assign categories.

Interpreting MIC results hinges on applying breakpoints that tie a numeric MIC to a clinical category. The MIC is the smallest drug concentration that inhibits growth in vitro, but by itself it doesn’t tell you whether that level of drug will work in a patient. Breakpoints are predefined thresholds for each organism–drug combination. If the MIC is at or below the breakpoint, the organism is considered susceptible; if it falls between breakpoints, it’s intermediate (often worth considering higher dosing or a specific site issue); if it is above the resistant breakpoint, the organism is resistant.

These breakpoints are carefully set using pharmacokinetics and pharmacodynamics (how the drug behaves in the body and at the infection site), achievable drug concentrations with standard dosing, and clinical outcome data. So the correct approach is to translate the MIC value into a category using those breakpoints rather than reading the MIC alone as the final interpretation.

The other statements overlook this: MIC alone isn’t the final verdict, so using it directly as S/I/R isn’t accurate; and disk diffusion uses zone diameters with separate interpretive criteria, not MIC values, to assign categories.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy